We use analytics to improve your experience. Cookie policy
NYSE · HEALTHCARE · Earnings
Next scheduled report, last quarterly EPS, consensus estimates, and TECHi commentary going into LLY's next print.
Next report
—
Confirmed schedule pending
EPS (TTM)
$28.13
P/E (trailing)
34.3x
Forward: 28.5x
Last EPS surprise
—
Beat history coming soon
Earnings desk view
The next confirmed earnings date and beat/miss history for Eli Lilly and Company are populated as the verified-snapshot pipeline lands this ticker. EPS + P/E above are pulled live from the unified fundamentals snapshot. For real-time commentary on LLY's next print, the news archive tracks every editorial reaction to earnings reports.
Frequently asked
Eli Lilly and Company reports quarterly. Track the latest scheduled date and consensus estimate on TECHi's LLY earnings page — updated whenever the company confirms the quarterly call.
Eli Lilly and Company's trailing earnings per share is approximately $28.13 based on the most recent fundamentals snapshot.
Eli Lilly and Company trades at a P/E ratio of approximately 34.3x trailing earnings.
TECHi's LLY earnings page covers the next scheduled report, the last several quarters of beats and misses, and editorial commentary tied to each release.
Beat / miss commentary for the most recent Eli Lilly and Company quarter is published on the TECHi LLY earnings page. Subscribe to the markets newsletter for the morning brief on every print.
